Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bazan

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Orphanet Journal of Rare Diseases|January 25, 2012
Novel C16orf57 mutations in patients with Poikiloderma with Neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutationsElisa A Colombo, J Fernando Bazan, Gloria Negri, et al.
Scientific Reports|March 8, 2022
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by ImmunohistochemistryZohair Selmani, Chloé Molimard, Alexis Overs, et al.
Cell Reports|October 19, 2022
Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27Katarzyna Składanowska, Yehudi Bloch, Jamie Strand, et al.
Journal of the American Chemical Society|April 23, 2025
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 InhibitorsHayden A Sharma, Michael Bielecki, Meredith A Holm, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2021
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patientsLaura Mansi, Laurie Spehner, Etienne Daguindau, et al.
The Oncologist|March 22, 2015
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?Xavier Pivot, Laura Mansi, Loic Chaigneau, et al.
Development (Cambridge, England)|September 6, 2021
Gene-teratogen interactions influence the penetrance of birth defects by altering Hedgehog signaling strengthJennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 InhibitorsHayden A Sharma, Michael Bielecki, Meredith A Holm, et al.
Clinical Breast Cancer|July 7, 2024
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast CancerAntoine El Kaddissi, Dewi Vernerey, Antoine Falcoz, et al.
Breast Cancer Research : BCR|December 24, 2025
Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitorsJustine Dutheil, Victor Pereira, Cyril Boisson, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Orphanet Journal of Rare Diseases|January 25, 2012
Novel C16orf57 mutations in patients with Poikiloderma with Neutropenia: bioinformatic analysis of the protein and predicted effects of all reported mutationsElisa A Colombo, J Fernando Bazan, Gloria Negri, et al.
Scientific Reports|March 8, 2022
Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by ImmunohistochemistryZohair Selmani, Chloé Molimard, Alexis Overs, et al.
Cell Reports|October 19, 2022
Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27Katarzyna Składanowska, Yehudi Bloch, Jamie Strand, et al.
Journal of the American Chemical Society|April 23, 2025
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 InhibitorsHayden A Sharma, Michael Bielecki, Meredith A Holm, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2021
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patientsLaura Mansi, Laurie Spehner, Etienne Daguindau, et al.
The Oncologist|March 22, 2015
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?Xavier Pivot, Laura Mansi, Loic Chaigneau, et al.
Development (Cambridge, England)|September 6, 2021
Gene-teratogen interactions influence the penetrance of birth defects by altering Hedgehog signaling strengthJennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 InhibitorsHayden A Sharma, Michael Bielecki, Meredith A Holm, et al.
Clinical Breast Cancer|July 7, 2024
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast CancerAntoine El Kaddissi, Dewi Vernerey, Antoine Falcoz, et al.
Breast Cancer Research : BCR|December 24, 2025
Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitorsJustine Dutheil, Victor Pereira, Cyril Boisson, et al.
Pageof 11